These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33971369)

  • 1. The Expression of NTAL and Its Protein Interactors Is Associated With Clinical Outcomes in Acute Myeloid Leukemia.
    Thomé CH; Ferreira GA; Pereira-Martins DA; Augusto Dos Santos G; Almeida-Silveira DR; Weinhäuser I; Antônio de Souza G; Houtsma R; Schuringa JJ; Rego EM; Faça VM
    Mol Cell Proteomics; 2021; 20():100091. PubMed ID: 33971369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.
    Thomé CH; Ferreira GA; Pereira-Martins DA; Dos Santos GA; Ortiz CA; de Souza LEB; Sobral LM; Silva CLA; Scheucher PS; Gil CD; Leopoldino AM; Silveira DRA; Coelho-Silva JL; Traina F; Koury LC; Melo RAM; Bittencourt R; Pagnano K; Pasquini R; Nunes EC; Fagundes EM; Gloria ABF; Kerbauy FR; Chauffaille ML; Keating A; Tallman MS; Ribeiro RC; Dillon R; Ganser A; Löwenberg B; Valk P; Lo-Coco F; Sanz MA; Berliner N; Faça VM; Rego EM
    Sci Rep; 2020 Jun; 10(1):10315. PubMed ID: 32587277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma.
    Ferreira GA; Thomé CH; Simão AMS; Scheucher PS; Silva CLA; Chahud F; Ciancaglini P; Leopoldino AM; Rego EM; Faça VM; Dos Santos GA
    Leuk Lymphoma; 2019 Nov; 60(11):2658-2668. PubMed ID: 31060403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated SH3BP5 Correlates with Poor Outcome and Contributes to the Growth of Acute Myeloid Leukemia Cells.
    Li M; Hao S; Li C; Xiao H; Sun L; Yu Z; Zhang N; Xiong Y; Zhao D; Yin Y
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31546831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
    Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
    Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.
    Huang J; Xiao R; Wang X; Khadka B; Fang Z; Yu M; Zhang L; Wu J; Liu J
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.
    Chen Y; Xie X; Wu A; Wang L; Hu Y; Zhang H; Li Y
    J Exp Clin Cancer Res; 2018 Jan; 37(1):12. PubMed ID: 29357910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-T cell activation linker promotes mast cell survival by dampening the recruitment of SHIP1 by linker for activation of T cells.
    Roget K; Malissen M; Malbec O; Malissen B; Daëron M
    J Immunol; 2008 Mar; 180(6):3689-98. PubMed ID: 18322174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT.
    Zhou H; Ning Y; Zeng G; Zhou C; Ding X
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
    Capala ME; Vellenga E; Schuringa JJ
    PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells.
    Tessarz AS; Weiler S; Zanzinger K; Angelisová P; Horejsí V; Cerwenka A
    J Immunol; 2007 Feb; 178(4):1991-9. PubMed ID: 17277102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia.
    Gong JN; Yu J; Lin HS; Zhang XH; Yin XL; Xiao Z; Wang F; Wang XS; Su R; Shen C; Zhao HL; Ma YN; Zhang JW
    Cell Death Differ; 2014 Jan; 21(1):100-12. PubMed ID: 24076586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
    Alachkar H; Santhanam R; Maharry K; Metzeler KH; Huang X; Kohlschmidt J; Mendler JH; Benito JM; Hickey C; Neviani P; Dorrance AM; Anghelina M; Khalife J; Tarighat SS; Volinia S; Whitman SP; Paschka P; Hoellerbauer P; Wu YZ; Han L; Bolon BN; Blum W; Mrózek K; Carroll AJ; Perrotti D; Andreeff M; Caligiuri MA; Konopleva M; Garzon R; Bloomfield CD; Marcucci G
    J Clin Invest; 2014 Apr; 124(4):1512-24. PubMed ID: 24590286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin Synergistically Enhances the Pro-Apoptotic Effect of Venetoclax on Acute Myeloid Leukemia Cells by Inhibiting AKT Signaling.
    Chen L; Li D; Guo X; Cheng C; Wei X
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):195. PubMed ID: 37796705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
    Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M
    Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.